Pages that link to "Q36288414"
Jump to navigation
Jump to search
The following pages link to Therapeutic role of beta-interferons in multiple sclerosis (Q36288414):
Displaying 31 items.
- PML clastosomes prevent nuclear accumulation of mutant ataxin-7 and other polyglutamine proteins (Q24683226) (← links)
- SOCS1 Mimetics and Antagonists: A Complementary Approach to Positive and Negative Regulation of Immune Function (Q28086933) (← links)
- Type I interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosis (Q28251763) (← links)
- Aberrant Type I Interferon Regulation in Autoimmunity: Opposite Directions in MS and SLE, Shaped by Evolution and Body Ecology (Q28299160) (← links)
- PEGylated interferon-beta modulates the acute inflammatory response and recovery when combined with forced exercise following cervical spinal contusion injury (Q33829033) (← links)
- Analyzing the metabolic stress response of recombinant Escherichia coli cultures expressing human interferon-beta in high cell density fed batch cultures using time course transcriptomic data (Q34088902) (← links)
- The safety and efficacy of IFN-beta products for the treatment of multiple sclerosis (Q34579232) (← links)
- The kinase inhibitory region of SOCS-1 is sufficient to inhibit T-helper 17 and other immune functions in experimental allergic encephalomyelitis (Q34645350) (← links)
- Transient oscillatory dynamics of interferon beta signaling in macrophages (Q34803273) (← links)
- Interferon regulatory factors in human lupus pathogenesis (Q34988497) (← links)
- Neopterin production and tryptophan degradation during 24-months therapy with interferon beta-1a in multiple sclerosis patients (Q35009131) (← links)
- Regulatory effects of mTORC2 complexes in type I IFN signaling and in the generation of IFN responses (Q35974114) (← links)
- Quantitative differences in the immunomodulatory effects of Rebif and Avonex in IFN-β 1a treated multiple sclerosis patients (Q36091339) (← links)
- Promoter-specific induction of the phosphatase SHP-1 by viral infection and cytokines in CNS glia (Q36174906) (← links)
- Evaluation of locomotor function and microscopic structure of the spinal cord in a mouse model of experimental autoimmune encephalomyelitis following treatment with syngeneic mesenchymal stem cells (Q36375008) (← links)
- Role of the Akt pathway in mRNA translation of interferon-stimulated genes (Q36534292) (← links)
- Therapeutic targeting of STAT pathways in CNS autoimmune diseases (Q36895435) (← links)
- Interferon-beta treatment in multiple sclerosis attenuates inflammatory gene expression through inducible activity of the phosphatase SHP-1. (Q37348839) (← links)
- Protozoan Parasites and Type I IFNs (Q37592659) (← links)
- Adrenergic and dopaminergic modulation of immunity in multiple sclerosis: teaching old drugs new tricks? (Q38052870) (← links)
- The molecular study of IFNβ pleiotropic roles in MS treatment (Q38163987) (← links)
- Effects of disruption of the nucleotide pattern in CRID element and Kozak sequence of interferon β on mRNA stability and protein production. (Q38896327) (← links)
- Decreased interferon-β induced STAT-4 activation in immune cells and clinical outcome in multiple sclerosis. (Q39130808) (← links)
- Dual regulatory roles of phosphatidylinositol 3-kinase in IFN signaling (Q41127803) (← links)
- Type I interferon in human autoimmunity (Q41452537) (← links)
- Interferon β induces clearance of mutant ataxin 7 and improves locomotion in SCA7 knock-in mice (Q48115369) (← links)
- Recurrent orbital inflammation in a patient with multiple sclerosis treated with interferon-beta. (Q53193470) (← links)
- Regulatory effects of mammalian target of rapamycin-activated pathways in type I and II interferon signaling. (Q53587646) (← links)
- 2-aminopurine suppresses the TGF-β1-induced epithelial-mesenchymal transition and attenuates bleomycin-induced pulmonary fibrosis. (Q55132895) (← links)
- Extensive infiltration of neutrophils in the acute phase of experimental autoimmune encephalomyelitis in C57BL/6 mice (Q82455889) (← links)
- Resiquimod-Mediated Activation of Plasmacytoid Dendritic Cells Is Amplified in Multiple Sclerosis (Q92636661) (← links)